LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $397,000 | -27.2% | 3,523 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $545,000 | +32.3% | 3,529 | +19.5% | 0.00% | 0.0% |
| Q3 2021 | $412,000 | +14.1% | 2,952 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $361,000 | +34.7% | 2,750 | +56.2% | 0.00% | +100.0% |
| Q1 2021 | $268,000 | -37.5% | 1,760 | -59.2% | 0.00% | -50.0% |
| Q4 2020 | $429,000 | +4.4% | 4,315 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $411,000 | -5.1% | 4,315 | +11.7% | 0.00% | 0.0% |
| Q2 2020 | $433,000 | +52.5% | 3,863 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $284,000 | +3.6% | 3,902 | +291.8% | 0.00% | +100.0% |
| Q3 2018 | $274,000 | +5.0% | 996 | -20.8% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | -0.4% | 1,258 | -20.8% | 0.00% | 0.0% |
| Q1 2018 | $262,000 | -1.9% | 1,588 | -18.4% | 0.00% | 0.0% |
| Q4 2017 | $267,000 | +23.6% | 1,947 | +22.9% | 0.00% | 0.0% |
| Q3 2017 | $216,000 | – | 1,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |